These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35101783)

  • 1. Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    He X; Dong B; Liang W; Wu Y; Chen Y; Dong Y; He J; Liu C
    Atherosclerosis; 2022 Mar; 344():1-6. PubMed ID: 35101783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
    Cunningham JW; Vaduganathan M; Claggett BL; John JE; Desai AS; Lewis EF; Zile MR; Carson P; Jhund PS; Kober L; Pitt B; Shah SJ; Swedberg K; Anand IS; Yusuf S; McMurray JJV; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2020 Aug; 8(8):618-626. PubMed ID: 32387067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
    Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH
    Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
    Bajaj NS; Kalra R; Gupta K; Aryal S; Rajapreyar I; Lloyd SG; McConathy J; Shah SJ; Prabhu SD
    ESC Heart Fail; 2020 Aug; 7(4):1676-1687. PubMed ID: 32424980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).
    Rahimi G; Tecson KM; Elsaid O; McCullough PA
    Am J Cardiol; 2021 Mar; 142():91-96. PubMed ID: 33279481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial).
    Gupta K; Kalra R; Rajapreyar I; Joly JM; Pate M; Cribbs MG; Ather S; Prabhu SD; Bajaj NS
    Am J Cardiol; 2020 May; 125(9):1347-1354. PubMed ID: 32151432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
    Segar MW; Patel KV; Ayers C; Basit M; Tang WHW; Willett D; Berry J; Grodin JL; Pandey A
    Eur J Heart Fail; 2020 Jan; 22(1):148-158. PubMed ID: 31637815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial.
    Vaduganathan M; Claggett BL; Chatterjee NA; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Hegde SM; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2018 Aug; 6(8):653-661. PubMed ID: 29501806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT.
    Ferreira JP; Liu J; Claggett BL; Vardeny O; Pitt B; Pfeffer MA; Solomon SD; Zannad F
    Eur J Heart Fail; 2022 Feb; 24(2):378-384. PubMed ID: 34755426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C
    Liang W; Wu Y; Xue R; Wu Z; Wu D; He J; Dong Y; Lip GYH; Zhu W; Liu C
    BMC Med; 2021 Feb; 19(1):44. PubMed ID: 33596909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent heart failure hospitalizations in heart failure with preserved ejection fraction: an analysis of TOPCAT trial.
    Wang Q; Yu F; Su H; Liu Z; Hu K; Wu G; Yan J; Chen K; Yang D
    ESC Heart Fail; 2024 Feb; 11(1):475-482. PubMed ID: 38054211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction.
    Angraal S; Mortazavi BJ; Gupta A; Khera R; Ahmad T; Desai NR; Jacoby DL; Masoudi FA; Spertus JA; Krumholz HM
    JACC Heart Fail; 2020 Jan; 8(1):12-21. PubMed ID: 31606361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.